Thyroid hormone levels after acute L-thyroxine loading in hypothyroidism

Area of Science:

• Endocrinology
• Pharmacology
• Thyroid Hormone Metabolism

Background:

• Levothyroxine (L-T4) is the standard treatment for hypothyroidism.
• Extrathyroidal conversion of T4 to T3 normally sustains circulating T3 levels.
• Acute administration of large L-T4 doses may cause a T3 surge beyond expected conversion.

Purpose of the Study:

• To investigate the source of increased serum T3 levels after acute, high-dose L-T4 administration.
• To determine if T3 contamination in L-T4 preparations contributes to this surge.
• To assess the clinical significance of T3 contamination in L-T4 therapy.

Main Methods:

• Administered 1000 micrograms of L-T4 (Synthroid) to hypothyroid individuals.
• Monitored serum T4 and T3 levels via continuous blood sampling.
• Analyzed L-T4 batches for T3 contamination using RIA.
• Administered T3 (Cytomel) to quantify its effect on serum T3 levels.

Main Results:

• Acute L-T4 administration led to rapid increases in both serum T4 and T3.
• RIA detected 0.7-0.9% T3 contamination in the L-T4 preparation.
• Administered T3 doses mimicked the T3 elevation seen after L-T4 administration.
• Peak T3 levels after L-T4 and equivalent T3 doses were identical.

Conclusions:

• The primary source of elevated serum T3 after acute high-dose L-T4 is T3 contamination in the L-T4 preparation.
• This T3 contamination is clinically significant, contributing to euthyroid T3 levels in acute regimens.
• The findings highlight the importance of purity in L-T4 formulations for accurate thyroid hormone management.